1887

Abstract

An expression cassette designed for high-level production of rabies virus glycoprotein (RG) could not be rescued into a replication-defective, adenovirus-based vector using standard procedures. To overcome this difficulty, a 293-based cell line, designated 293LAP13, was constructed that contained and expressed a derivative of the lac repressor protein. The lac operator sequence, to which the repressor binds, was incorporated into an expression cassette, containing a promoter and intron, designed for high-level production of RG. Insertion of a single operator sequence immediately downstream of the transcription start site and the use of the 293LAP13 cell line allowed recombinant viruses that could not be isolated with 293 cells to be rescued efficiently. The operator-containing virus reached higher titres in 293LAP13 than in parental 293 cells and also produced plaques more efficiently in 293LAP13 cells. Moreover, in non-complementing human and canine cell lines, adenovirus vectors with a promoter-intron expression cassette expressed RG at much higher levels than vectors lacking the intron. These observations, together with the demonstration that expression of RG by operator-containing vectors was repressed markedly in 293LAP13 cells and that this inhibition was relieved at least partly by IPTG, suggest that the 293LAP13 cell line may be useful for the rescue and propagation of many vectors in which high expression of the desired protein prevents vector rescue in 293 cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-2-345
1999-02-01
2022-08-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/2/0800345a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-2-345&mimeType=html&fmt=ahah

References

  1. Addison C. L., Hitt M., Kunsken D., Graham F. L. 1997; Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgenic expression by adenoviral vectors. Journal of General Virology 78:1653–1661
    [Google Scholar]
  2. Beltz G. A., Flint S. J. 1979; Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. Journal of Molecular Biology 131:353–373
    [Google Scholar]
  3. Berkner K. L., Sharp P. A. 1985; Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Research 13:841–857
    [Google Scholar]
  4. Bett A. J., Haddara W., Prevec L., Graham F. L. 1994; An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proceedings of the National Academy of Sciences, USA 91:8802–8806
    [Google Scholar]
  5. Bett A., Krougliak V., Graham F. L. 1995; DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309. Virus Research 39:75–82
    [Google Scholar]
  6. Charlton K. M., Artois M., Prevec L., Campbell J. B., Casey G. A., Wandeler A. I., Armstrong J. 1992; Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Archives of Virology 123:169–179
    [Google Scholar]
  7. Choi T., Huang M., Gorman C., Jaenisch R. 1991; A generic intron increases gene expression in transgenic mice. Molecular Cell Biology 11:3070–3074
    [Google Scholar]
  8. Dorsch-Hasler K., Keil G. M., Weber F., Jasin M., Schaffner W., Koszinowski U. H. 1985; A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA of murine cytomegalovirus. Proceedings of the National Academy of Sciences, USA 82:8325–8329
    [Google Scholar]
  9. Graham F. L. 1984; Covalently closed circles of human adenovirus DNA are infectious. EMBO Journal 3:2917–2922
    [Google Scholar]
  10. Graham F. L., Prevec L. 1995; Methods for construction of adenovirus vectors. Molecular Biotechnology 3:207–220
    [Google Scholar]
  11. Graham F. L., van der Eb A. J. 1973; A new technique for the assay of infectivity of adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  12. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  13. Hitt M., Bett A. J., Addison C. L., Prevec L., Graham F. L. 1995; Techniques for human adenovirus vector construction and characterization. Methods in Molecular Genetics 7:13–30
    [Google Scholar]
  14. Hitt M. M., Addison C. L., Graham F. L. 1997; Human adenovirus vectors for gene transfer into mammalian cells. Advances in Pharmacology 40:137–206
    [Google Scholar]
  15. Hitt M., Bett A. J., Prevec L., Graham F. L. 1998; Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook 2nd edn vol 1 pp 500–512 Edited by Celis J. E. London: Academic Press;
    [Google Scholar]
  16. Jones N., Shenk T. 1979; Isolation of adenovirus type 5 host range deletion mutants defective for transformation ofrat embryo cells. Cell 16:683–689
    [Google Scholar]
  17. Kaufman R. J., Sharp P. A. 1982; Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression. Molecular and Cellular Biology 11:1304–1319
    [Google Scholar]
  18. Labow M. A., Baim S. B., Shenk T., Levine A. J. 1990; Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Molecular and Cellular Biology 10:3343–3356
    [Google Scholar]
  19. Massie B., Couture F., Lamoureux L., Mosser D. D., Guilbault C., Jolicoeur P., Belanger F., Langelier Y. 1998; Inducible over-expression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. Journal of Virology 72:2289–2296
    [Google Scholar]
  20. Matthews K. S., Nichols J. C. 1998; Lactose repressor protein: functional properties and structure. Progress in Nucleic Acid Research and Molecular Biology 58:127–164
    [Google Scholar]
  21. Matthews D. A., Russell W. C. 1994; Adenovirus protein-protein interactions: hexon and protein VI. Journal of General Virology 75:3365–3374
    [Google Scholar]
  22. Mittereder N., March K. L., Trapnell B. C. 1996; Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. Journal of Virology 70:7498–7509
    [Google Scholar]
  23. Nadin-Davis S. A., Casey G. A., Wandeler A. 1993; Identification of regional variants of the rabies virus within the Canadian province of Ontario. Journal of General Virology 74:829–837
    [Google Scholar]
  24. Natesan S., Rivera V. M., Molinari E., Gilman M. 1997; Transcriptional squelching re-examined. Nature 139:349–350
    [Google Scholar]
  25. Petitclerc D., Attal J., Theron M. C., Bearzotti M., Bolifraud P., Kann G., Stinnakre M. G., Pointu H., Puissant C., Houdebine L. M. 1995; The effect of various introns and transcription terminators on the efficiency of expression vectors in various cultured cell lines and in the mammary gland of transgenic mice. Journal of Biotechnology 40:169–178
    [Google Scholar]
  26. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  27. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  28. Tomanin R., Bett A. J., Picci L., Scarpa M., Graham F. L. 1997; Development and characterization of a binary gene expression system based on bacteriophage T7 components in adenovirus vectors. Gene 193:129–140
    [Google Scholar]
  29. Xiang Z. Q., Yang Y., Wilson J. M., Ertl H. C. 1996; A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220–227
    [Google Scholar]
  30. Yang U. C., Huang W., Flint S. J. 1996; mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells. Journal of Virology 70:4071–4080
    [Google Scholar]
  31. Yarosh O. K., Wandeler A. I., Graham F. L., Campbell J. B., Prevec L. 1996; Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14:1257–1264
    [Google Scholar]
  32. Yew N. S., Wysokenski D. M., Wang K. X., Ziegler R. J., Marshall J., McNeilly D., Cherry M., Osburn W., Cheng S. H. 1997; Optimization of plasmid vectors for high-level expression in lung epithelial cells. Human Gene Therapy 8:575–584
    [Google Scholar]
  33. Yoshida Y., Hamada H. 1997; Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochemical and Biophysical Research Communications 230:426–430
    [Google Scholar]
  34. Yoshida Y., Emi N., Hamada H. 1997; VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochemical and Biophysical Research Communications 232:379–382
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-2-345
Loading
/content/journal/jgv/10.1099/0022-1317-80-2-345
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error